Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Roivant Sciences (ROIV) Return on Capital Employed: 2021-2025

Historic Return on Capital Employed for Roivant Sciences (ROIV) over the last 4 years, with Sep 2025 value amounting to -0.25%.

  • Roivant Sciences' Return on Capital Employed fell 102.00% to -0.25% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.25%, marking a year-over-year decrease of 102.00%. This contributed to the annual value of -0.18% for FY2025, which is 83.00% down from last year.
  • According to the latest figures from Q3 2025, Roivant Sciences' Return on Capital Employed is -0.25%, which was down 25.41% from -0.20% recorded in Q2 2025.
  • Roivant Sciences' Return on Capital Employed's 5-year high stood at 0.96% during Q4 2023, with a 5-year trough of -0.69% in Q3 2022.
  • For the 3-year period, Roivant Sciences' Return on Capital Employed averaged around 0.19%, with its median value being 0.24% (2024).
  • Its Return on Capital Employed has fluctuated over the past 5 years, first surged by 156bps in 2023, then crashed by 102bps in 2025.
  • Roivant Sciences' Return on Capital Employed (Quarterly) stood at -0.48% in 2021, then dropped by 12bps to -0.60% in 2022, then skyrocketed by 156bps to 0.96% in 2023, then dropped by 21bps to 0.75% in 2024, then crashed by 102bps to -0.25% in 2025.
  • Its Return on Capital Employed stands at -0.25% for Q3 2025, versus -0.20% for Q2 2025 and 0.75% for Q4 2024.